Outcomes of the infant Ross procedure for congenital aortic stenosis followed into adolescence  by Elder, Robert W. et al.
Congenital Heart Disease Elder et al
C
H
DOutcomes of the infant Ross procedure for congenital aortic stenosis
followed into adolescenceRobert W. Elder, MD,a Jan M. Quaegebeur, MD, PhD,b Emile A. Bacha, MD,b Jonathan M. Chen, MD,b
Francois Bourlon, MD,c and Ismee A. Williams, MD, MSaFrom th
Cardi
geons
York,
aco, M
Dr Willi
Deve
of thi
resen
Deve
Disclosu
Receive
public
Address
ment
gan S
North
0022-52
Copyrig
http://dx
1504Objectives: The Ross procedure is used to treat aortic valve disease in children. The advantages include auto-
graft growth, long-term durability, and avoidance of anticoagulation. Long-term follow-up of the Ross proce-
dure in infancy is limited. We sought to characterize the long-term outcomes of infants undergoing the Ross
procedure.
Methods:We performed a retrospective review of all patients who underwent a Ross operation at 18 months of
age or younger at New-York Presbyterian and Cardiothoracic Center ofMonaco from 1991 to 2010. The clinical,
catheterization, and surgical records were reviewed. The most recent follow-up information, including echocar-
diogram and electrocardiogram, was obtained and analyzed.
Results: A total of 34 patients underwent a Ross procedure at a median age of 6 months (range, 4 days to 18.4
months). All had congenital aortic stenosis. All but 1 patient had undergone previous surgical or catheter-based
interventions. The median follow-up was 10.6 years (range, 1.4-20.4 years). There were 4 early deaths and 1 late
transplant. The freedom from right ventricular outflow tract reintervention was 85% at 5 years and 64% at
10 years. The freedom from autograft reintervention was 95.5% at 10 years. In 20 subjects, late follow-up echo-
cardiograms showed a significant difference between the mean early and late Z scores of the autograft annulus
(0.8 vs 2.4, P ¼ .03), sinus (0.8 vs 2.8, P ¼ .002), and sinotubular junction (1.2 vs 2.7, P ¼ .04). Mild or less
aortic insufficiency occurred in 17 subjects. None had significant aortic stenosis.
Conclusions: The long-term outcomes of the Ross procedure in infants and toddlers are favorable despite mod-
erate dilatation of the autograft. Reintervention at the right ventricular outflow tract is common. (J Thorac Car-
diovasc Surg 2013;145:1504-11)TheRoss procedure uses the native pulmonary valve as an au-
tograft to replace a diseased aortic valve.1 Although some
critics consider the procedure controversial in that it places
2 valves at risk of future surgical intervention, it has a number
of advantages, including the potential for autograft growth,
long-term durability, and avoidance of anticoagulation.2
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The Journal of Thoracic and Cardiovascular Surlimited. In particular, infants who undergo a Ross procedure
might represent a distinct subgroup and could have different
long-term outcomes, given the relative plasticity of the pul-
monary valve at that age. Most infants and toddlers who
undergo a Ross procedure have aortic stenosis (AS), and
some have multiple levels of left-sided obstructive disease.
Most infants who require the procedure have undergone
previous interventions, and many are critically ill at surgery.
Unlike adult candidates, young patients rarely have isolated
aortic insufficiency (AI).
Two reports have been published that address the mid-
term outcomes of infants who have undergone a Ross pro-
cedure.3,4 The first study by Williams and colleagues3 was
published in 2005 and examined the outcomes of 27 infants
and toddlers. There were 3 early and no late deaths. At a me-
dian follow-up of 6 years, the autograft showed good func-
tion despite moderate dilation.3 More recently, Shinkawa
and colleagues4 published follow-up data from 31 infants
who had undergone an early Ross at younger than 12months
of age. At a median follow-up of 6 years, survival was 76%
and freedom from reoperation at 10 years was 50.6%.4
The purpose of the present study was to examine a large
cohort of infant and toddler Ross patients and significantly
extend the duration of follow-up for the group into late ad-
olescence. In using the original cohort of patients from thegery c June 2013
Abbreviations and Acronyms
AI ¼ aortic insufficiency
AS ¼ aortic stenosis
BAV ¼ balloon aortic valvuloplasty
CHB ¼ complete heart block
EFE ¼ endocardial fibroelastosis
LVOT ¼ left ventricular outflow tract
RCA ¼ right coronary artery
RVOT ¼ right ventricular outflow tract
STJ ¼ sinotubular junction
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of the survival, need for reintervention, and function of
the autograft, including the degree of dilatation over time.
METHODS
Study Design
All patients who underwent a Ross operation at 18 months of age or
younger at Children’s Hospital of New-York Presbyterian and the Cardio-
thoracic Center of Monaco from May 1991 to June 2010 were included.
The institutional review board of each institution approved the study and
waived informed consent. The medical and surgical records were reviewed
to obtain the preoperative data, including age at surgery, gender, body
surface area, indications for the procedure, and previous interventions. Op-
erative data, including surgery type, homograft type, additional procedures,
cardiopulmonary bypass time, crossclamp time, and complications were
recorded. Follow-up data from all survivors were requested from the pri-
mary cardiologist, including vital status, most recent echocardiogram
and electrocardiogram (ECG), and the need for reintervention, including
surgery and catheterization. The hospital records were reviewed to aug-
ment the information from the primary cardiologist.
Surgical Technique
The surgical technique has been previously described.3 In brief, the Ross
procedure was performed using the root replacement technique without the
aid of rings, pledgets, or other reinforcements. The proximal suture line of
the autograft was placed below the level of the native aortic annulus to use
the natural support structure of the left ventricular outflow tract (LVOT).
Whennecessary, additional surgical procedures, such as themodifiedKonno
procedure, were included. All patients received antegrade cold blood cardi-
oplegia delivered directly into the coronary arteries, as required, every 30 to
40 minutes. The last dose was infused into the aorta after completion of the
aortic root reconstruction to assess for bleeding and autograft insufficiency.
ECG Analysis
All available ECGs were analyzed by a single cardiologist (R.W.E.).
The QRS duration was measured and considered to indicate incomplete
bundle branch block if greater than the 98th percentile for age5 and com-
plete bundle branch block if the QRS duration was longer than 120 ms.
When the ECG was not available for review, the primary cardiologist’s
interpretation was used.
Echocardiographic Analysis
The echocardiograms from the preoperative period, early postoperative
period, and most recent follow-up examination were centrally reviewed by
a single cardiologist (I.A.W.). AI, as judged by color Doppler analysis and
examination of the descending aortic Doppler flow signal, was graded on
a scale of 0 to 4 (0, none; 1, trivial; 2, mild; 3, moderate; and 4, severe).The Journal of Thoracic and CarAutograft measurements were made off-line in systole at the valve annulus,
sinus, and sinotubular junction (STJ); preoperative measurements of the
native pulmonary valve were made at the level of the annulus. An average
of 3 measurements was used. Z scores of the autograft were calculated
according to the expected norms for the aortic dimensions for body surface
area.6 Continuous wave Doppler analysis of the LVOTand right ventricular
(RV) outflow tract (RVOT) were reviewed, and the peak instantaneous
velocity was recorded.
Statistical Analysis
Continuous variables are reported as the mean standard deviation and
categorical values as the count and percentage. Kaplan-Meier estimates of
survival and freedom from reintervention were calculated. Z scores from
the early postoperative and most recent echocardiograms were compared
using the paired Student t test. An a-value of< .05 was considered signif-
icant for all analyses, except in the case of multiple comparisons, in which
the Bonferroni correction method was used.
RESULTS
Patient Characteristics
From May 1991 to June 2010, we identified 34 patients
who had undergone a Ross procedure at 18 months of age
or younger, 27 from the original cohort3 and 7 since 2004
(Table 1). Most (n ¼ 27, 79%) had undergone surgery at
the Children’s Hospital of New York and 7 had undergone
surgery at the Cardiothoracic Center of Monaco. The
median age at the Ross procedure was 6 months (range,
4 days to 18.4 months); 26 (76.5%) were boys. All the pa-
tients had a primary diagnosis of congenital AS, 12 of
whom had isolated valvar AS. The remaining 22 patients
had complex left-sided obstructive lesions with associated
subvalvar AS (n ¼ 15), supravalvar AS (n ¼ 2), mitral ste-
nosis (n ¼ 3), endocardial fibroelastosis (EFE, n ¼ 6), co-
arctation (n ¼ 8), and interrupted aortic arch (n ¼ 2).
All but 1 patient had undergone an intervention before
the Ross procedure. Catheter-based balloon aortic valvulo-
plasty (BAV) occurred in 22 patients, 9 had undergone sur-
gical valvotomy, and 11 had undergone previous surgical
repair of associated lesions, such as coarctation or interrup-
ted aortic arch.
Preoperative Echocardiographic Assessment
In a subset of 20 patients for whom the immediate pre-
Ross echocardiogram was available, the pulmonary and
aortic root size was measured. The pulmonary annulus
was, on average, 1.6 times larger than the aortic annulus.
Compared with normative values, the mean Z score for
the pulmonary annulus was 0.38  1.2, and the mean
Z score for the aortic annulus was1.93  1.5.
Operative Course
At the Ross operation, 26 of the 34 patients underwent
a Konno modification either to relieve subaortic obstruction
or because of the small size of the aortic annulus. Additional
concurrent surgical procedures includedmitral valvuloplasty
in 6, EFE resection in 4, ventricular septal defect repair in 2,diovascular Surgery c Volume 145, Number 6 1505
TABLE 1. Patient characteristics
Pt. no.
Previous
balloon
valvuloplasty
Previous
surgical
intervention
Primary
indication
for Ross
Age at
Ross (d)
Weight at
surgery
(kg) Konno
RVOT conduit
Vital status
Follow-up
(y)Type
Size
(mm)
1 No CoA AS/AI 171 7.9 Yes Ao 15 Alive 10.8
2 Yes None AI 36 3 Yes Ao 9.5 Died NA
3 Yes None AS/AI 516 8.6 No Ao 17 Alive 16.1
4 Yes CoA AS/AI 246 5.7 Yes PH 20 Alive 1.4
5 No CoA AS 71 9.2 Yes Ao 15 Alive 8.5
6 Yes None AS/AI 234 8 Yes PH 14.5 Alive 10.0
7 Yes None AS 122 4 Yes PH 11 Alive 10.5
8 No None AS 382 8.3 No PH 15.5 Alive 9.5
9 Yes None AS/AI 14 3.2 Yes PH 11 Transplant 15.2
10 Yes None AS/AI 4 2.9 Yes PH 8 Alive 2.5
11 Yes None AI 28 3.2 Yes Porcine 14 Alive 13.1
12 No SVal AI 273 8 Yes PH 16 Alive 12.0
13 Yes CoA AS/AI 14 3.6 Yes PH 9 Died NA
14 No SVal/CoA AS/AI 51 4.5 Yes PH 16 Alive* 0.0
15 Yes None AS/AI 55 5.5 Yes PH 15 Alive 8.2
16 No SVal AS 102 4.7 No PH 15 Alive 18.8
17 No 1: IAA-R, PAB,
sub-AS-R
2: VSDR, PAB-R
AS 175 4.3 Yes PH 20 Died NA
18 Yes None AS/AI 46 3.6 Yes Porcine 14.5 Alive 13.9
19 Yes None AS/AI 368 8.7 Yes Ao 16 Alive* 0.0
20 No SVal AS 250 8 No PH 15 Alive 20.4
21 Yes None AS/AI 105 4.9 Yes PH 10 Alive 4.7
22 No SVal AS 77 4.8 Yes PH 16 Alive 17.7
23 No CoA AS/AI 186 3.5 Yes PH 17 Alive 6.5
24 Yes None AS 421 5.6 No PH 17 Alive 5.2
25 Yes None AI 406 9.5 Yes Ao 17 Alive 15.0
26 No IAA-R, VSDR AS 281 5.6 Yes PH 14 Alive 6.9
27 Yes SVal AS 19 3.2 Yes Ao 15 Alive 13.8
28 Yes CoA (arch), SVal,
VSDR
AS 450 7.5 Yes Ao 15 Died NA
29 Yes CoA AS/AI 471 11.2 No PH 23 Alive 2.8
30 Yes CoA AS/AI 227 5 No PH 16 Alive 14.2
31 No SVal AS/AI 154 3.9 Yes Ao 22 Alive 16.1
32 Yes None AS 367 10 Yes Ao 17 Alive 13.7
33 Yes None AS/AI 552 9.2 No PH 20 Alive 6.5
34 Yes None AS/AI 270 8.7 Yes PH 17 Alive 8.3
AS, Aortic stenosis; AI, aortic insufficiency; Ao, aortic homograft; CoA, coarctation repair; CoA (arch), repair of hypoplastic arch; IAA-R, repair of interrupted aortic arch;NA, not
applicable;PA, pulmonary artery;PAB, placement of PA band; PAB-R, removal of PA band; PH, pulmonary homograft;Porcine, porcine heterograft; Pt. no., patient number; SVal,
surgical valvotomy; sub-AS-R, resection of subaortic stenosis; VSDR, ventricular septal defect repair. *Alive at discharge.
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closure in 2.Themean cardiopulmonary bypass timewas 173
 35 minutes, and the mean aortic crossclamp time was 118
 27 minutes. Replacement of the native pulmonary valve
was accomplished using an aortic homograft in 10 patients,
a pulmonary homograft in 22 patients, and a porcine hetero-
graft in 2 patients. The mean size of the homograft placed at
the Ross procedure was 15  3.4 mm.
Mortality
Of the entire cohort, 4 perioperative deaths occurred, all
occurred within the first 24 to 48 hours. A 1-month-old1506 The Journal of Thoracic and Cardiovascular Surinfant, in whom transfer of the right coronary artery
(RCA) was technically challenging secondary to a large
size discrepancy between the small native aorta and larger
pulmonary autograft, died of a right ventricular infarct. A
1-year-old patient developed bilateral pneumothoraces
postoperatively, was unable to be resuscitated, and died.
A 2-week-old, 3.6-kg infant with a small left ventricle
and significant EFE died in the operating room because
the left ventricle was unable to support systemic circulation
to wean off cardiopulmonary bypass. Finally, a critically ill,
5-month-old infant with complex LVOT obstruction and
pulmonary hypertension died after homograft rupture.gery c June 2013
FIGURE 2. Freedom from right ventricular outflow tract reintervention.
Number above x-axis indicates number at risk at given period. PA,
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late survivors, with a median duration from surgery to the
latest follow-up examination of 10.6 years (range, 1.4-
20.4 years). The overall survival of the entire cohort at
10 years was 88.2% (Figure 1).
One early survivor (patient 9, Table 1) required a heart
transplant 15.2 years after the Ross procedure. This patient
had been born with critical AS and EFE and underwent
BAV in the immediate neonatal period that resulted in
severe aortic valve incompetence. The Ross procedure
was performed at 14 days of age. He underwent pulmonary
valve replacement 9 years later. At 14 years old, he devel-
oped progressive heart failure symptoms. An echocardio-
gram at that time demonstrated his autograft functioning
well with only trivial AI and no significant stenosis. He
underwent cardiac transplantation, and pathologic exami-
nation of the explanted heart showed an unremarkable auto-
graft with well-endothelilized coronary artery buttons.
Histologic examination of the left ventricular myocardium
showed focal endocardial thickening, myocyte hypertrophy,
and patchy subendocardial fibrosis. No other late deaths or
transplantations occurred in the present series.Pulmonary artery; RV, right ventricle.RVOT Outcomes
The freedom from any RVOT reintervention at 5, 10, and
15 years was 85%, 64%, and 23%, respectively (Figure 2).
Surgical replacement of the right ventricle to pulmonary ar-
tery (PA) conduit occurred in 9 and catheter-based proce-
dures in 6. Of these 6 patients, 4 had a stent placed in the
RVOT, 1 underwent balloon dilation of the RVOT, and 1FIGURE 1. Overall freedom from death or transplantation. Number
above x-axis indicates number at risk at given period.
The Journal of Thoracic and Carunderwent placement of a transcutaneous Melody valve
for relief of stenosis and regurgitation. Of the 4 patients
who had a stent placed in the RVOT, 3 subsequently re-
quired surgical replacement of the conduit (1 each 8 months
later, 3.5 years later, and nearly 8 years later). At the writing
of our report, we were aware of 2 other patients in the series
who have been referred for RVOT surgical revision: 1 had
previously undergone conduit replacement and 1 has not
had any RVOT interventions since the Ross procedure.
Autograft Outcomes
Of the entire cohort, freedom from autograft reinterven-
tion was 95.5% at 10 years, with only 1 patient requiring
reintervention 5.7 years after the Ross procedure (patient
7, Table 1). The patient had AS and sub-AS and had under-
gone a Ross-Konno procedure at 2 months of age after
unsuccessful BAV. He slowly developed progressive sub-
AS associated with significant AI and at 6 years of age un-
derwent surgical repair of his autograft with simultaneous
relief of RVOT obstruction. Intraoperatively, the left coro-
nary cusp was elongated with associated prolapse and insuf-
ficiency of the valve and significant residual sub-AS. Repair
of the valve and resection of the subaortic tissue was under-
taken. At the most recent follow-up visit, the patient had
moderate AI and mild AS (<20 mm Hg).
ECG Analysis
Late-term ECGs were available for 29 of the 30 survivors
of the infant Ross procedure. One infant with Shonediovascular Surgery c Volume 145, Number 6 1507
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2 months of age developed operative complete heart block
(CHB) requiring a permanent pacemaker. No other CHB
was noted among the survivors. Of the 4 early deaths, 1 pa-
tient had had CHB, 2 had not had CHB, and 1 patient had no
ECG available for review. The other ECG findings in the
long-term survivors included sinus bradycardia (n ¼ 1),
first-degree heart block (n¼ 1), incomplete (n¼ 5) or com-
plete (n ¼ 3) right bundle branch block, left-anterior hemi-
block (n ¼ 3), and left bundle branch block (n ¼ 1).Echocardiographic Analysis
Late follow-up echocardiogram measurements were
available for 20 subjects (66%) at a mean of 10.3  5.2
years after the Ross procedure and were compared with
the early postoperative echocardiogram measurements ob-
tained at a mean of 11 8 days postoperatively. At the latest
follow-up examination, the autograft dimension Z scores
were elevated and showed dilatation at all 3 measured levels
(Figure 3, A). A significant difference was seen between the
mean early and late Z scores of the autograft annulus (0.8 vs
2.4, P ¼ .03), sinus (0.8 vs 2.8, P ¼ .002), and STJ (1.2 vsFIGURE 3. Comparison of early postoperative and late echocardiograms
(echo) in 20 patients. A, Late echocardiogram showing dilatation (Z score
>2) at annulus, sinus, and sinotubular junction (STJ),with statistically sig-
nificant difference between early and late echocardiogram mean Z scores.
*P .05, **P .002. B, Comparison of aortic insufficiency quantification.
1508 The Journal of Thoracic and Cardiovascular Sur2.7, P ¼ .04). Autograft function remained good in most
patients, with AI quantified as mild or less in 17 subjects,
mild to moderate in 1, and moderate in 2 (Figure 3, B).
Of the 2 patients with moderate AI, 1 had previously under-
gone surgical reintervention at the level of the autograft but
5 years after the reintervention continued to have moderate
insufficiency. None of the long-term follow-up echocardio-
grams showed significant AS (>20 mm Hg).
To address the progression of autograft dilatation over
time, serial echocardiograms were examined in a subset of
14 patients at 3 points: early postoperatively (median, 8
days), midterm (median, 4.5 years), and at the latest
follow-up visit (median, 11.4 years). When the Z scores
for the early and midterm echocardiograms were compared,
significant dilatation had occurred at all 3 levels (P<.001;
Figure 4, A). When the midterm and late echocardiograms
were compared, a trend was seen toward decreased Z scores
at all 3 levels, although only the STJ showed a significantly
decreased Z score (P ¼ .003, Figure 4, A). Scatter plots of
the 14 patients’ Z scores over time at the 3 intervals demon-
strated variability in the individual response (Figure 4,B-D).
Associated Interventions and Long-Term
Complications
Two patients required subsequent cardiovascular surgical
interventions other than revision of the RVOT or autograft:
1 required resection of a supramitral valve membrane 1.5
years after the Ross procedure and 1 underwent diagnostic
catheterization for homograft stenosis 14 years after the
Ross procedure and was found to have a previously unrec-
ognized anomalous left upper pulmonary vein draining to
the innominate vein that was repaired at the same time as
the conduit replacement.
Long-term medical complications developed in 3
patients. One patient with CHB required multiple pace-
maker revisions. Streptococcal endocarditis developed in
1 patient 12 years after the Ross procedure and 9 years after
right ventricle to PA conduit replacement. A third patient
underwent diagnostic cardiac catheterization 11 years after
the Ross procedure and was incidentally found to have
occlusion of the proximal RCA with collateral filling of
the right coronary distribution. The patient was asymptom-
atic, and a recent nuclear stress test showed no evidence of
flow-limited coronary artery disease.
DISCUSSION
We report the results of a large series of 34 patients, who
had undergone a Ross procedure at 18 months of age or
younger, with an extended follow-up, nearly doubling the
median length of follow-up from the 2 previous largest
series.3,4 At a median duration of 10.6 years after the
Ross operation, all but 1 of the surviving patients in our
study remained free from significant autograft disease
requiring reintervention.gery c June 2013
FIGURE 4. Follow-up of serial autograft dilatation in subset of 14 patients. A, Comparison of mean Z scores at 3 intervals. Individual Z scores for, B,
annulus, C, sinus, and, D, sinotubular junction (STJ) at 3 points. **P  .003. Ao, Aortic.
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a critically ill group of patients with limited surgical options
at presentation. Although complex aortic valve repair has
been described with respectable intermediate-term results,7
the technical challenges in the infant makes this a less ten-
able option. Furthermore, 76% of our group required
a Konno modification to address LVOT obstruction, which
would not be addressed by aortic valve repair alone. Most
of the patients required initial catheter-based BAV. Some
required an urgent Ross procedure for subsequent
procedure-related significant AI, a known complication of
BAV that occurs in 22% to 29% of infants.8,9
Despite the challenges of surgery in this young, critically
ill, group of patients, the mortality and long-term outcomes
were quite favorable compared with both general pediat-
ric10-12 and young infant subpopulations of the Ross
procedure.4 In our group, 4 patients died in the early postop-
erative period.Of the 4 deaths, 3 (75%) occurred before 2000The Journal of Thoracic and Carand none in the past 10 years. Also, 2 of the 4 deaths occurred
in infants 1 month old or younger at the Ross procedure. One
death was secondary to a small left ventricle with significant
EFE, the other was secondary to the technical challenges of
the Ross procedure that relate to transfer of the RCAwhen
a large size discrepancy is present between the larger PA
and the smaller aorta. During the study period, withmany pa-
tients followed up into adolescence, only 1 additional patient
with a history of EFE at birth, who underwent the Ross pro-
cedure at 14 days of age, ultimately required cardiac trans-
plantation. No late deaths occurred in our series.
Infants, in particular, might be better suited to the Ross
procedure. When the semilunar valves of mice were ana-
lyzed histochemically, Colvee and Hurle13 showed that
the collagen and mucopolysaccharide composition of the
valves continued to change postnatally. They concluded
that ‘‘maturation of the valves occurs over a long period
of the postnatal life.’’13 The microscopic structure of thediovascular Surgery c Volume 145, Number 6 1509
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adapt to the hemodynamic changes of systemic circulation
when the Ross procedure is performed in infancy.
Autograft Outcomes
The neoaortic root did appear to be dilated, with late-term
echocardiograms showing Z scores greater than the norm. In
our series, a statistically significant difference was seen
between the Z scores for the autograft dimensions for the an-
nulus, sinus, and STJ at the latest follow-up examination and
those from the echocardiograms in the early postoperative pe-
riod. Solowiejczyk and colleagues14 studied a pediatric pop-
ulation of Ross patients and showed progressive dilatation of
the autograft over time compared with the normal aortic di-
mensions.Comparedwith theZ scores for a pulmonary trunk,
the autograft showed less pronounced dilatation. Others have
similarly showed that most pediatric patients have autograft
Z scores outside the norm for the aortic root.10,15
In the series of 31 infants reported by Shinkawa and col-
leagues,4 the discharge echocardiograms already showed
significant dilatation, with a mean Z score of the annulus
and STJ of 4.3 and 4.0, respectively. When they compared
those early values with measurements derived from later
echocardiograms (performed at a median of 6 years after
Ross), no statistically significant difference was found, sug-
gesting that the timing of the discharge echocardiogram had
already captured the dilatation. It is possible that in our
study the early postoperative echocardiogram measured at
a mean of 11 days was too soon after surgery to show the
dilatation, or, perhaps, differences in surgical technique
were present between the centers. When we evaluated the
serial measurements of the autograft over time in a subpop-
ulation, the dilatation appeared to occur early, with the com-
parison of the mid and late echocardiograms showing little
change or in some cases decreased Z scores. This suggests
that the autograft does not continue to dilate with time but,
rather, stabilizes compared with the body surface area in
this age group.
Regardless of dilatation, the function of the autograft is of
primary importance after a Ross procedure. In our series and
others,10-12 very few patients have required reintervention of
the autograft. The vast majority of patients in the present
series had mild or less insufficiency and were asymptomatic
at their latest follow-up visit. None of the patients had signif-
icant residual AS. We believe that in this particular young
group, no other procedure is available that will provide the
same hemodynamic advantages.
RVOT Outcomes
Many critics are concerned because the Ross procedure
places 2 valves at risk of future problems. Many of our
group did require reintervention of the right ventricle to
PA conduit, as expected with associated somatic growth.
However, despite their young age at the initial operation,1510 The Journal of Thoracic and Cardiovascular Sur64% had still not required any procedural intervention of
the right ventricle to PA conduit at 10 years of follow-up.
In this era of advances in percutaneous interventions, it is
noteworthy that 6 of the 15 initial interventions were cath-
eter based, including placement of 1 Melody valve. In the
future, this group of young Ross patients might be candi-
dates for transcatheter valve therapy, especially as the pop-
ulation ages and might require a second or third right
ventricle to PA conduit intervention.
ECG Analysis
Although the infant subgroupmight seem to be at a greater
risk of CHB, in our series, only 1 late-term survivor had
CHB. Pasquali and colleagues16 reported rhythm and con-
duction disturbances in a pediatric Ross population at
a median of 8.7 years postoperatively; 4% had CHB, a num-
ber similar to that in our infant group. This suggests that
despite the younger age and smaller size at surgery, in expe-
rienced hands, the risk to the conduction system is compara-
ble to that in older patients. In the series by Pasquali and
colleagues,16 when they analyzed the Holter results, sinus
node dysfunction was found in 15% and another 15% had
ventricular tachycardia. Although Holter studies were not
consistently available for our cohort, the late follow-up
ECGs showed a number of conduction disturbances that
probably warrant Holter monitoring during follow-up.
Surgical Considerations
One of the technical surgical challenges of the Ross pro-
cedure in young infants occurs when a marked size discrep-
ancy is present between the native pulmonary and aortic
annuli. In particular, relocation of the RCA button can be
challenging, and in 3 patients in our series, the RCAwas re-
implanted into the noncoronary sinus of the autograft to
minimize tension on the RCA. Relocation of the coronary
arteries can be associated with morbidity and mortality.
One patient in whom the RCAwas implanted into the nor-
mal, anterior sinus died of an RCA infarct. One survivor, in
whom the coronary arteries were also normally reim-
planted, was incidentally discovered by catheterization to
have RCA occlusion with good collateralization.
Study Limitations
Our study was limited by its retrospective nature. Of the
group of 30 late survivors, 2 patients were lost to follow-up.
Also, 8 of the patients with known follow-up data did not
have a recent echocardiogram available for analysis. Given
that the echocardiograms and ECGs were not consistently
available, analysis of subgroups was performed that could
have biased the overall findings. Finally, the present study
did not address more functional analyses of the patients’
status, such as maximal exercise testing, which could be
a helpful alternative to understanding subtle differences in
functional capacity.gery c June 2013
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DCONCLUSIONS
The long-term outcomes of the Ross procedure in infants
and toddlers are favorable despite moderate dilatation of the
autograft. Reintervention at the RVOT is common.
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